Therefore, we use meta-analysis in Oncomine platform to assess TET3 gene expression in ovarian cancer [10], followed by integration analysis using a larger sample size including 14 studies in GEO datasets [11], and further validated with gene expression from TCGA and GTEx. The gene discussed is TET3; the disease is ovarian carcinoma.